topic
Good news about Medicine
Positive stories about Medicine, gathered from the newsrooms Rally reads. Every headline links back to the publisher who reported it.
The 100 most recent of 106 stories.
Same-day test helps doctors detect hidden infections in critically ill children
Metagenomics offers a new way of detecting infections in intensive care patients.
BBC News
'Spain's hallmark in Vatican': The Spanish medical science behind Pope Francis' lung operation
Spanish surgeon Diego González Rivas developed a groundbreaking lung surgery technique that was used to treat Pope Francis. The minimally invasive Uniportal VATS method reduces recovery time and improves outcomes for patients. This advance highlights Spain's contributions to medical science.
Euronews
TimeTeller puts our internal clocks at the center of personalized medicine
A German startup has created a saliva test to help people understand their circadian rhythm, aiming to improve cancer treatment by reducing side effects. The approach offers a more reliable alternative to past health-testing controversies, giving patients and doctors better tools for personalized care.
TechCrunch
How Germany is training medical staff to fight Ebola
German medical experts are training healthcare workers in Uganda to safely treat Ebola patients, helping contain the virus in eastern DR Congo. The training focuses on protecting staff while caring for those infected, offering hope in the fight against the deadly outbreak.
Euronews
FDA-Approved Drug Could Be Repurposed to Relieve Osteoarthritis Pain And Protect Cartilage
Researchers are always looking out for drugs that can be repurposed for something else. The main benefit is that these treatments have already passed various safety tests, which means they can be made available more quickly for new conditions.
ScienceAlert
A Cheap Deworming Pill Could Help Beat Drug-Resistant Lung Cancer
A common deworming drug may offer a new way to fight drug-resistant lung cancer. The discovery could help patients whose cancer cells have learned to evade treatment. It’s a promising step toward overcoming a major challenge in cancer care.
ScienceAlert
HOLDING IT TOGETHER: Humour helps healthcare staff cope in a way that is therapeutic
Humour in healthcare settings helps staff and patients cope with stress and grief, creating moments of levity even in difficult situations. It can ease burnout for doctors and reduce patients’ risk of depression, offering a small but meaningful way to navigate hardship. This simple, human approach makes a real difference in challenging environments.
Daily Maverick
October 17 — Heart Fit Clinic
Heart Fit Clinic offers advanced screening to detect cardiovascular risks like irregular heart rhythms and plaque buildup, going beyond standard tests. Their personalized approach helps people uncover hidden heart health concerns early, providing clear answers and a path forward. This proactive care can make a meaningful difference in preventing serious conditions.
Global News
The best strategy against superbugs: Wait 48 hours before taking antibiotics, and only use them if symptoms worsen
Spain’s Health Ministry and regional governments are encouraging doctors to delay prescribing antibiotics for respiratory infections, a safe approach to reduce antibiotic resistance. The strategy helps patients avoid unnecessary medication while combating the growing threat of superbugs. It’s a small but meaningful step toward better health outcomes.
El País (English)
THE CONVERSATION: How pond algae led to a Nobel and new ways to study the brain
Three researchers won a Nobel Prize for discovering new ways to control nerve cells, starting with a simple question about pond algae. Their work could lead to better treatments for brain disorders. It’s a reminder that curiosity and persistence can unlock major breakthroughs.
Daily Maverick
Slew of events planned in memory of K.V. Thiruvengadam in centenary year
A series of events will honor the legacy of a celebrated physician, emphasizing patient-centered care and thoughtful medical practice. The celebrations aim to restore the art of listening and bedside examination, ensuring his principles continue to inspire future generations. This tribute highlights the enduring impact of compassionate, reflective medicine.
The Hindu
World Medical Association adopts policy combatting false health information
First-of-its-kind policy comes at a time when doctors must compete with misleading online content
The Globe and Mail
Frozen testicular tissue transplanted in bid to restore fertility after chemotherapy
Protecting fertility is a major challenge for young men undergoing aggressive treatments such as chemotherapy. Freezing their own testicular tissue before such treatments could help.
Euronews
An experimental drug kills fat cells, rather than shrinking them
Participants in two small trials lost dangerous fat around their internal organs. This fat is linked to health issues like diabetes and heart problems.
Science News
Two Chemists Win Nobel Prize for Unraveling a Mystery of Molecular 'Handedness,' Helping Drugmakers Develop Safer Medications
Two chemists have solved a long-standing mystery about molecular "handedness," helping drugmakers create safer, more precise medications. Their work allows scientists to produce only the biologically active form of molecules, a breakthrough that could improve treatments. This discovery is a significant step forward for medical research and patient care.
Smithsonian Magazine
Exclusive: Suki, UpToDate Bring AI Clinical Decision Support Into Workflows
Suki's new AI tool surfaces patient-specific clinical guidance, combining medical records with evidence-based info from UpToDate.
Newsweek
Pediatricians renew call to ban raw milk as anti-science rhetoric reigns
Pediatricians are renewing their call to ban raw milk, emphasizing the safety of pasteurization to protect children’s health. The move counters anti-science rhetoric and reinforces long-standing medical advances. It’s a step toward safeguarding kids from preventable illnesses.
Ars Technica
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
New data shows that Nemluvio® (nemolizumab) provides lasting relief from skin lesions and itch for atopic dermatitis patients aged 12 and older, with many responders maintaining benefits for up to three years. The findings, presented at a dermatology conference, also confirm the drug’s consistent safety profile, offering hope for long-term treatment.
Financial Post
USask professor recognized for pediatric stem cell research
Dr. Tyler Wenzel’s work in pediatric stem cell research is making progress in treating rare childhood diseases. Recognized as a Rising Star by Canada’s Stem Cell Network, his innovative approach is advancing regenerative medicine and improving care for young patients. This breakthrough highlights the potential to transform lives through cutting-edge science.
Global News
Gene therapy and special goggles give some blind people limited sight
A breakthrough in optogenetics lets some blind people see shapes and objects for the first time, thanks to special goggles paired with gene therapy. The treatment helps cells in the eye respond to light, restoring limited vision. It’s a hopeful step for those with vision loss.
Science News
Trio of Scientists Wins Medicine Nobel for a Method to Turn Nerve Cells On and Off With Light, Helping to Unravel the Brain's Mysteries
This year’s Nobel Prize in Physiology or Medicine honors three scientists for developing optogenetics, a technique that uses light to control nerve cells and study their links to behavior. Their work helps researchers explore the brain’s connections to emotions and memories, offering new ways to unravel its mysteries. The breakthrough is a major step forward in neuroscience.
Smithsonian Magazine
Bone density and other muscular tests for women to be offered through Healthier SG: Ong Ye Kung
Singapore will soon offer women screening tests for bone density and muscle health under the Healthier SG programme. These tests can help detect osteoporosis and sarcopenia, conditions that affect mobility and quality of life. The move aims to catch and treat these issues earlier, improving long-term health outcomes.
The Straits Times
2026 Nobel Prize in Physiology or Medicine awarded to Karl Deisseroth, Georg Nagel and Peter Hegemann for work on optogenetics
This year’s Nobel Prize in Physiology or Medicine honors the inventors of optogenetics, a breakthrough that lets scientists use light to control individual cells. The technology has advanced research into brain function and disease. It’s a win for medical science and the patients who may benefit from future treatments.
Scientific American
Nobel medicine prize goes to 3 scientists for research into brain activity
Three scientists have been awarded the Nobel Prize in medicine for uncovering how the brain controls nerve cell activity. Their work helps us understand how the brain functions at a fundamental level, offering hope for new treatments for neurological disorders. This discovery is a major step forward in brain research.
NPR
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Drugmakers are developing amylin-based treatments to complement or expand on existing obesity and diabetes drugs, offering new options for those who don’t respond well to current GLP-1 therapies. This could help millions of people achieve better health outcomes.
CNBC
Greece to set up a new national dementia centre for patients, families and caretakers
Greece is launching a new national dementia center in Athens to support patients, families, and caregivers with cognitive training, therapy, and ongoing care. The facility will offer prevention, diagnosis, and monitoring services, creating a more comprehensive approach to dementia and Alzheimer’s treatment. This initiative marks a significant step forward in improving care for those affected.
Euronews
Nine Patients Received a Personalized Kidney Cancer Vaccine. None Had a Recurrence.
A new vaccine uses proteins from a patient’s own tumor to train the immune system to recognize kidney cancer. In a small trial, none of the nine patients treated had a recurrence. This approach could offer a personalized way to fight cancer.
ScienceAlert
Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
A new Phase III trial shows Boehringer Ingelheim’s survodutide helped people with obesity and type 2 diabetes lose up to 13.1% of their body weight, alongside improved blood sugar control. This is particularly meaningful for a group where weight loss is often challenging. The results could offer a promising new treatment option for those managing both conditions.
Financial Post
Calgary cyclotron to make radiopharmaceuticals for fighting cancer expected by 2029
A new cyclotron in Calgary will produce radiopharmaceuticals to help diagnose and treat cancer, using advanced technology to create radioactive materials for medical scans and treatments. This development will improve access to life-saving care, offering hope to patients and their families.
Global News
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Eli Lilly’s new obesity treatment, combining eloralintide with tirzepatide, helped patients lose more weight than tirzepatide alone in mid-stage trials. The results could offer a more effective option for people with obesity and Type 2 diabetes. The company plans to start final-stage trials later this year.
CNBC
MRI Scans Might Reveal Signs of Alzheimer's Disease Seven Years Before a Telltale Marker Appears in the Brain
Early MRI scans may detect brain changes linked to Alzheimer’s years before key protein buildups appear, offering a potential new way to study the disease. While not yet a diagnostic tool, the findings could help researchers better understand how Alzheimer’s progresses, bringing hope for earlier insights and interventions.
Smithsonian Magazine
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
New data shows Nemluvio® continues to improve skin lesions, itch, and sleep for people with moderate-to-severe atopic dermatitis over three years. The treatment is well-tolerated, offering lasting relief and better quality of life for adults and adolescents. This long-term success marks a meaningful advance for those managing this chronic condition.
Financial Post
How vaccines and antibiotics can beat some cancers
A new study shows that vaccines and antibiotics could prevent nearly all of the 2.3 million cancer cases caused by common infections in 2024. This breakthrough offers hope for millions by tackling a major cause of cancer. It’s a reminder of how simple tools can save lives.
The Telegraph
Team of skydivers drop in to help survivors of a plane crash in Wisconsin
Recreational jumpers used their training as paramedics to treat crash victims before ground crews arrived
The Guardian
A medieval remedy could offer ideas for beating antibiotic resistance
A 10th-century remedy called Bald’s eyesalve fights bacteria in multiple ways, offering new clues for modern medicine. Researchers recreated the treatment and found it worked better than expected, suggesting its molecule mixtures could inspire solutions to antibiotic resistance. This could help scientists develop new ways to combat tough infections.
Science News
Lupin gets U.S. FDA tentative nod for Apixaban Oral Suspension
Lupin has received tentative approval from the U.S. FDA for its Apixaban Oral Suspension, a move that could expand access to a crucial medication. This development offers hope for patients who rely on this treatment, marking a step forward in healthcare innovation. The approval reflects progress in making essential therapies more widely available.
The Hindu
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
Oncolytics Biotech has activated nearly all clinical sites for its REO 033 study, enrolling multiple patients with a specific type of colorectal cancer. The company expects to share interim data by the end of 2026, potentially speeding up approval for a treatment that could help patients with limited options. This progress offers hope for faster access to new therapies.
Financial Post
Science Talk: Why a greener medication box matters to your health
Pharmacists at Tan Tock Seng Hospital redesigned medication boxes to use only paper, removing plastic for easier recycling. The change helps the environment and patients by making packaging more sustainable. It’s a simple but meaningful step toward reducing waste in healthcare.
The Straits Times
NTU study could offer clues to overcoming cancer drug resistance
Researchers at NTU have identified potential ways to tackle cancer drug resistance, offering hope for more effective treatments. The study could help patients whose cancer cells develop resistance, improving their chances of recovery. This progress brings us closer to overcoming a major challenge in cancer care.
The Straits Times
Non-verbal, non-mobile S’pore girl joins global hackathon where experts try to solve medical mysteries
A young girl in Singapore with an undiagnosed condition joined a global hackathon to find answers. The event brought experts together to solve medical mysteries, offering hope to families like hers. This effort could lead to better care and a brighter future.
The Straits Times
Scientists Invent a Digestible, Paper-Based Battery That Can Power Swallowed or Implanted Medical Devices
So far, the technology has been tested only in pigs. If it's successful in humans, it could one day power tools that monitor your health or deliver drugs or electrical currents inside the body
Smithsonian Magazine
Blood test for multiple cancers clears crucial hurdle on track to FDA approval
A blood test for multiple cancers has cleared a key step toward FDA approval, offering hope for earlier detection. The Galleri test could help identify cancers before symptoms appear, potentially improving treatment outcomes. This progress marks a significant advance in cancer screening.
Scientific American
IHC seeks Pakistan Medical and Dental Council view on doctors’ working hours
The Islamabad High Court is reviewing doctors’ working hours, calling a 102-hour work week "inhuman" and citing international limits like 48 hours in Europe. This could lead to better working conditions for medics, improving their well-being and patient care. The move highlights growing recognition of the need for fairer labor standards in healthcare.
Dawn
Pharmacy treatments for Lyme disease cut N.S. emergency visits in half: study
Blacklegged tick bites can lead to Lyme disease, as well as Anaplasmosis, Babesiosis and Powassan virus though Nova Scotia has not seen Powassan cases so far.
Global News
EU sends experts to Congo as Ebola outbreak continues; Congo receives vaccines for clinical trials
European experts are traveling to the heart of Congo’s Ebola outbreak to support response efforts. Meanwhile, clinical trials for the Ervebo vaccine have begun, offering hope for better protection. This coordinated action could help contain the crisis and save lives.
Euronews
Doing more with less: A Singaporean surgeon’s lessons from a hospital between two Sudans
A Singaporean surgeon is sharing expertise with a hospital in Sudan, performing complex surgeries to help patients in need. His experience offers valuable lessons in delivering care with limited resources, improving outcomes for those who might otherwise go untreated. This collaboration highlights the power of global medical support in underserved communities.
The Straits Times
Experts discuss specific diagnosis and brain modulation in Alzheimer’s care
Experts are highlighting the value of precise Alzheimer’s diagnosis and exploring non-invasive brain stimulation as a promising tool in dementia care. This approach could improve treatment outcomes and quality of life for patients. The focus on early, accurate diagnosis and innovative therapies offers hope for better care.
The Hindu
Drug Clears Disease Markers in 78% of Patients With Pre-Cancerous Blood Disorder
A new treatment shows promise for high-risk smoldering multiple myeloma, a pre-cancerous blood disorder. The trial found it cleared disease markers in most patients, offering hope for those at risk of developing a more serious cancer. This could mean better outcomes for people facing this challenging condition.
ScienceAlert
Teva Announces New Olanzapine LAI (TEV-‘749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Teva’s new long-acting injectable for schizophrenia, TEV-‘749, showed high stabilization rates and long-term efficacy in a Phase 3 trial. More than half of participants stabilized, and over a fifth achieved remission after six months. This could offer a more convenient, effective treatment option for adults with the condition.
Financial Post
Medical Innovation Benefits the People: Highlights of the 2026 Beijing Capital International Medical Conference
The 2026 Beijing Capital International Medical Conference brought together global health leaders to advance medical innovation and cooperation, with a focus on improving health equity and wellbeing for all. Participants emphasized how shared progress in medical development can benefit individuals, families, and communities worldwide.
Financial Post
Blood test shows promise in detecting pancreatic cancer early—a ‘holy grail’ for the field
A new blood test offers hope for early detection of pancreatic cancer, which is often caught too late due to its subtle early symptoms. This could help patients receive treatment sooner, improving survival chances. The test represents a significant step forward in a field where early diagnosis has been elusive.
Scientific American
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
Boehringer Ingelheim has launched a new online learning hub to empower patients by elevating their voices in healthcare discussions. PED Essentials will help patient organizations gather and analyze insights on symptoms, quality of life, and treatment preferences, enhancing advocacy efforts. This initiative brings valuable patient experience data to the forefront, fostering a more informed dialogue between patients and healthcare stakeholders.
Financial Post
Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
Curium™ has received FDA approval for BEXLUTRY, the first radioligand therapy for adults with SSTR-positive gastrointestinal neuroendocrine tumors (GEP-NETs). This significant milestone marks a new treatment option for patients, bringing hope for improved outcomes in a challenging area of healthcare.
Financial Post
NUS researchers use magnetic pulses to turn cancer-promoting immune cells into cancer fighters
Researchers at the National University of Singapore have successfully transformed cancer-promoting immune cells into cells that fight cancer, specifically targeting breast cancer. This innovative approach offers a promising alternative to traditional chemotherapy, potentially improving treatment options for patients and enhancing their quality of life.
The Straits Times
‘Father of emergency medicine’ among 17 doctors to receive apex title in S’pore medical field
Seventeen doctors and dentists, including Venkataraman Anantharaman and Phua Kong Boo, were honored with the Eminent Academician title. The recognition highlights their contributions to Singapore’s medical field, celebrating excellence and dedication. This honor uplifts the profession and inspires future generations of healthcare leaders.
The Straits Times
PT Health Watch: How laboratory tests can help detect colorectal cancer early – Expert
Early detection of colorectal cancer is now possible through laboratory tests, even when symptoms are absent. This helps people identify the disease sooner, improving treatment outcomes. The news offers hope for better health management and early intervention.
Premium Times
AI is Accelerating Drug Discovery: McKernan
AI is speeding up drug discovery by analyzing health data and improving clinical trials, making medicine more personalized. While some parts of development can’t be rushed, the technology is already helping patients and researchers. This progress could lead to faster, more targeted treatments in the future.
Bloomberg
A Psychedelic Compound Found in 'Magic' Mushrooms Might Prevent Debilitating Nerve Damage and Pain Caused by Chemotherapy
A study suggests psilocybin, found in "magic" mushrooms, may protect against nerve damage caused by chemotherapy. Researchers are now launching a mid-stage clinical trial to test its potential in preventing peripheral neuropathy, a painful side effect that affects many cancer patients. This could offer hope for reducing long-term pain and discomfort.
Smithsonian Magazine
Statins Linked to Lower Dementia Risk in Massive Type 2 Diabetes Study
A large Danish study suggests that starting statin treatment soon after a type 2 diabetes diagnosis may reduce the risk of dementia. The earlier patients begin treatment, the better the potential benefit. This offers hope for people managing diabetes and their long-term brain health.
ScienceAlert
Arthritis Drug Restores Up to 100% of Hair in Patients With Severe Alopecia
Around 2 percent of the world's population has to live with the severe hair loss and associated psychological toll that comes with alopecia areata, a condition caused by the immune system mistakenly attacking hair follicles.
ScienceAlert
Can we change how we age? ST launches year-long series The New Age on living long, and living well
The Straits Times is launching a year-long series to rethink ageing, showing how lifestyle, medicine, and social support can turn it into a time of opportunity. The project offers practical insights for anyone looking to live longer and better, shifting the focus from decline to possibility.
The Straits Times
Investing in the future of health: Singapore’s growing longevity sector
Private healthcare groups and commercial players are expanding access to biological age testing, precision diagnostics, and personalised lifestyle interventions. This innovation helps people take proactive steps to improve their health and longevity. The growing sector offers new tools for better, longer lives.
The Straits Times
GLP-1 Weight-Loss Drugs Can Slow Aging and Extend Life Span, Mouse Study Suggests
Older female mice given daily injections of semaglutide, the active ingredient in GLP-1 drugs like Ozempic, lived about 12 percent longer than untreated mice. The findings suggest these medications may slow aging and extend lifespan, offering potential benefits beyond weight loss and diabetes management. If confirmed in humans, this could be a significant breakthrough in longevity research.
Smithsonian Magazine
New Zealand approves party-drug MDMA for treating patients with PTSD
New Zealand has become the second country to allow psychiatrists to prescribe MDMA for treating severe PTSD, following Australia’s lead. This approval, based on clinical trial results, offers hope to patients with limited treatment options. The move highlights progress in exploring alternative therapies for mental health conditions.
Euronews
Transplanted pig kidney works in US man's body for record 271 days
A man has survived for nine months with a transplanted pig kidney, setting a new record. This breakthrough offers hope to patients waiting for human transplants. The success shows progress in using animal organs to save lives.
BBC News
Weight-loss pill "Wegovy" available in German pharmacies from 1 September
Germany is now the first EU country to offer Wegovy, a weight-loss pill that increases feelings of fullness. This approval marks a milestone for Novo Nordisk and provides a new option for adults seeking to manage their weight. The medication will be available in pharmacies from September.
Euronews
'Wonder Drug': Common Diabetes Pill Could Transform How We Age, Scientists Say
A widely used diabetes drug could offer new ways to improve health as we age, according to scientists. The discovery builds on decades of existing treatment, offering hope for longer, healthier lives. This research suggests simple solutions may hold the key to major breakthroughs.
ScienceAlert
The FDA Just Approved The First US Freeze-Dried Plasma, Ready in Minutes
For a patient losing blood, every minute without treatment can matter. But the plasma needed to help control bleeding isn't always available where the injury happens.
ScienceAlert
These Patients Couldn't Beat Lyme Disease, So Scientists Tried Giving Them Psilocybin
Scientists are testing psilocybin to help patients with Lyme disease who haven’t responded to other treatments. This could offer new hope for those struggling with the most common insect-borne illness in the U.S. The research highlights a creative approach to tackling persistent health challenges.
ScienceAlert
Distinction for Pakistani hospital
Shifa International Hospitals has earned the most Joint Commission International accreditations in Pakistan, a mark of excellence in healthcare. This recognition highlights the hospital’s commitment to high standards, benefiting patients who rely on top-tier medical care. It’s a win for quality and trust in the country’s health services.
Dawn
This common medication cuts heart-attack risk in older people
A world-first clinical trial shows that cholesterol-lowering medication can cut the risk of heart attack and stroke by 30% in healthy older adults. The findings suggest millions of independent older Australians may soon be advised to take the drug. This could prevent serious cardiovascular events and improve health outcomes for many.
The Sydney Morning Herald
Senegalese company produces first Africa-made treatment for sickle cell disease
Africa accounts for nearly 80 per cent of cases of the inherited red blood cell disorder but has relied on expensive imported medication.
Africanews
U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease
The FDA has approved a new drug that extends the lives of people with pancreatic cancer, a disease notoriously difficult to treat. This breakthrough offers hope to patients facing one of the most challenging forms of cancer.
Scientific American
One Type of Diabetes Responds Better to a Weekly GLP-1 Drug Than to Insulin
GLP-1 (glucagon-like peptide-1) drugs are now perhaps best known in relation to weight loss, but they were originally developed – and continue to be widely used – for diabetes.
ScienceAlert
A New Personalized Cancer Vaccine Could Keep Skin Cancer From Coming Back, Drugmakers Say
A new personalized cancer vaccine, tested alongside an existing treatment, has shown promise in preventing melanoma from returning or spreading in a late-stage trial. The results bring the vaccine closer to approval, offering hope for more effective, tailored treatments for skin cancer. This could mark a step forward in fighting the disease.
Smithsonian Magazine
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
A new mRNA cancer vaccine has shown success in a Phase 3 trial for melanoma, helping patients avoid recurrence and spread. The treatment is personalized to target each patient’s unique cancer mutations, offering a promising new approach to fighting this deadly skin cancer.
Ars Technica
Vaccine breakthrough stops cancer returning in trial
A personalised vaccine, combined with a drug, has prevented skin cancer from returning in trial patients, offering hope for longer remission. While the long-term effects are still unclear, this breakthrough marks a significant step forward in cancer treatment. The approach could help many people stay cancer-free for longer.
BBC News
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%
A new cancer vaccine from Moderna and Merck has shown promising results in its first late-stage trial, significantly extending the time melanoma patients live without their cancer returning. The treatment could offer a new option for those battling the disease, bringing hope for future approval.
CNBC
Research integrating Western medicine and TCM gets boost under new collaboration
A new collaboration is advancing research that combines Western medicine and traditional Chinese medicine, supported by a professorship in healthcare and technology. This partnership aims to improve medical treatments and benefits patients by integrating different approaches. The initiative highlights a commitment to innovative, holistic healthcare solutions.
The Straits Times
The COVID-19 vaccine may offer brain cancer patients a surprise benefit
Glioblastoma patients who received a COVID-19 vaccine before surgery lived twice as long as those who didn’t. The effect wasn’t seen with other vaccines, suggesting a unique benefit. This unexpected finding could offer new hope for brain cancer treatment.
Science News
US Cardiologists Issue New Guidelines For How to Manage Cholesterol
The American Heart Association has updated its cholesterol guidelines to help doctors manage high LDL levels, which affect about one in four US adults. The changes aim to reduce heart attack and stroke risks by improving treatment strategies. This is good news for people at risk of cardiovascular disease.
ScienceAlert
Madrid hospital creates first bone metamaterial prosthesis, prevents leg amputation
Madrid's Gregorio Marañón Hospital has created the world's first personalised metamaterial bone prosthesis, successfully implanted in a 38-year-old with tibial sarcoma, avoiding leg amputation.
Euronews
Popular drug metformin transforms your gut into a sugar sink
Scientists have uncovered how metformin, a widely prescribed diabetes drug, helps the body manage blood sugar by transforming the gut into a sugar-storing reservoir. This discovery could improve treatments for type 2 diabetes and prevention efforts. The finding offers hope for better health outcomes for millions of people.
Scientific American
Estrogen therapy is linked to fewer signs of Alzheimer’s in the brain
Older women on estrogen-only therapy show fewer Alzheimer’s plaques and tangles in their brains. While it may not prevent the disease, the therapy could reduce its severity. This offers hope for better brain health during menopause.
Science News
Newborn screening for cancer risk could save lives. Should it be done?
New genetic screening could detect cancer-linked mutations in newborns, giving doctors an early chance to intervene. While it carries risks, the potential to save lives makes it a promising development. This could expand the benefits of newborn screening beyond the conditions currently tested.
Science News
Could Psilocybin Help Treat Anorexia? A Small Clinical Trial Suggests the Psychedelic May Make Patients More Open to Recovery
A small clinical trial suggests psilocybin, combined with therapy, may help people with anorexia become more open to recovery by loosening rigid thought patterns. Some participants even asked for food during sessions, offering hope for a condition that often resists treatment. Researchers stress it’s not a cure, but the results are promising.
Smithsonian Magazine
First-of-its-kind clinic treats psychedelic side effects
A new clinic is offering specialized care for side effects from psychedelic treatments, which are gaining wider acceptance. This support helps patients as more states legalize the drugs and research expands. The growing public backing for medical use makes this progress especially meaningful.
Scientific American
Sperm with DNA damage might be the true cause of repeated miscarriages
New research suggests sperm DNA damage may explain repeated miscarriages, offering hope to couples struggling with infertility. This discovery could lead to better treatments and a clearer path to parenthood for those who have faced heartbreak. The findings highlight a previously overlooked factor in reproductive health.
Scientific American
After Receiving a Custom Experimental Medicine, a Teen With a Rare Genetic Disorder Walked on His Own for the First Time
A teenager with a rare genetic disorder, who had never walked alone, took his first steps after receiving an experimental, personalized treatment. His progress, along with another boy’s, shows how tailored medicine can help where standard drugs fail. The breakthrough offers hope for others with severe, untreatable conditions.
Smithsonian Magazine
Inside the trial for a vaccine to end malaria
Volunteers in Oxford are testing an experimental vaccine that could help end malaria, a disease that has plagued humanity for centuries. If successful, the trial could bring hope to millions at risk. This is a crucial step toward eradicating a deadly and widespread illness.
The Telegraph
Woman has pioneering womb surgery to fix 'miracle' baby with intestines outside its body
Doctors performed a groundbreaking in-utero surgery to correct a rare birth defect, helping a baby born with intestines outside its body. This trial marks the first time the procedure has been used in the UK, offering hope for future cases. The successful outcome highlights the potential of prenatal care to improve outcomes for babies and families.
BBC News
Diabetes Drug Used For More Than 60 Years Found to Unexpectedly Affect The Brain
A decades-old diabetes drug has been found to have unexpected effects on the brain, offering new insights into how it works. This discovery could help people with type 2 diabetes in ways researchers didn’t anticipate. It’s a reminder that even well-established treatments still have surprises to reveal.
ScienceAlert
New drug for super-gonorrhoea points to better antibiotic development
A new drug for super-gonorrhoea could help break the cycle of long waits for antibiotics. This development offers hope for faster treatment and better health outcomes, especially in areas where the disease is a growing threat. It’s a step forward in the fight against antibiotic resistance.
The Telegraph
How A.I. Will Reshape Radiology—Without Replacing Radiologists
Radiologists are finding that AI enhances their work rather than replacing them, thanks to the irreplaceable value of human expertise. The technology improves diagnostics, but doctors’ flexibility and experience remain essential. This collaboration ensures better care while preserving skilled medical roles.
Smithsonian Magazine
Healthy pregnancies and newborns are possible after CAR T cell therapy
A new study shows that women who received CAR T cell therapy for autoimmune diseases like lupus can have healthy pregnancies and babies. This reassuring finding offers hope to patients who may have feared long-term effects on fertility. The results highlight the therapy’s potential to treat disease without compromising future family planning.
Science News
Medical tribunal redefines standards of ‘negligence’
ISLAMABAD: The medical tribunal has delivered two significant judgements redefining the legal standards governing professional negligence, expert medical evidence and disciplinary proceedings against registered medical practitioners.
Dawn
The quest to keep organs alive outside the body
Researchers are exploring new ways to preserve organs outside the body, such as freezing or supercooling them, to extend their viability. This could help address the critical shortage of donor organs by creating organ banks. The breakthrough offers hope for more transplant options and saves lives.
MIT Technology Review
Supercooled kidneys have been transplanted into pigs in a “landmark achievement”
A breakthrough in organ storage could extend the time kidneys remain viable for transplant, using subzero temperatures in special containers. This may help more people receive life-saving transplants by reducing the urgency of immediate surgery. The method offers hope for longer-term storage of donated human organs.
MIT Technology Review
Tansplanted testicular tissue grew sperm in an infertile patient
A breakthrough in testicular transplants has restored sperm production in an infertile patient, offering new hope to people whose fertility was affected by cancer or other diseases. The procedure marks a rare success in a field with a difficult history, paving the way for future advancements in reproductive health.
Scientific American
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
Eli Lilly’s next-generation obesity drug has cleared two more late-stage trials, bringing the total to five successful studies. The company plans to seek approval in early 2027, offering hope for more treatment options. This progress could expand care for people struggling with obesity.
CNBC
